Literature DB >> 16170668

An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.

Hue H Luu1, Quan Kang, Jong Kyung Park, Weike Si, Qing Luo, Wei Jiang, Hong Yin, Anthony G Montag, Michael A Simon, Terrance D Peabody, Rex C Haydon, Carrie W Rinker-Schaeffer, Tong-Chuan He.   

Abstract

Osteosarcoma is the most common primary malignancy of bone and patients often develop pulmonary metastases. In order to investigate the pathogenesis of human osteosarcoma, there is a great need to develop a clinically relevant animal model. Here we report the development of an osteosarcoma animal model using three related human osteosarcoma lines, the parental TE-85 and two derivative lines MNNG/HOS and 143B. In vitro characterization demonstrated that the 143B line had the greatest cell migration and the least cell adhesion activities among the three lines. The 143B line also exhibited the greatest ability for anchorage independent growth. When GFP-tagged osteosarcoma cells were injected into the proximal tibia of athymic mice, we found that 143B cells were highly tumorigenic and metastatic, and MNNG/HOS cells were tumorigenic but significantly less metastatic. TE85 cells were neither tumorigenic nor metastatic. The number of pulmonary metastases was found 50-fold higher in 143B injected animals than that in MNNG/HOS injected mice. No pulmonary metastases were detected in TE85 injected animals for up to 8 weeks. Primary tumors formed by MNNG/HOS and 143B cells could be visualized by whole body fluorescence imaging, while the pulmonary metastases were visualized on the necropsied samples. The GFP tagged 143B cells (and to a lesser extent, MNNG/HOS cells) were readily recovered from lung metastases. This clinically relevant model of human osteosarcoma provides varying degrees of tumor growth at the primary site and metastatic potential. Thus, this orthotopic model should be a valuable tool to investigate factors that promote or inhibit osteosarcoma growth and/or metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 16170668     DOI: 10.1007/s10585-005-0365-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

2.  Cultivation in vitro of cells derived from a human osteosarcoma.

Authors:  R M McAllister; M B Gardner; A E Greene; C Bradt; W W Nichols; B H Landing
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

3.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

4.  An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.

Authors:  C Khanna; J Prehn; C Yeung; J Caylor; M Tsokos; L Helman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  A gene involved in control of human cellular senescence on human chromosome 1q.

Authors:  P J Hensler; L A Annab; J C Barrett; O M Pereira-Smith
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

6.  Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.

Authors:  Elizabeth A Lafleur; Nadezhda V Koshkina; John Stewart; Shu-Fang Jia; Laura L Worth; Xiaoping Duan; Eugenie S Kleinerman
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

7.  Identification of a novel metastasis-suppressor region on human chromosome 12.

Authors:  H H Luu; G P Zagaja; Z Dubauskas; S L Chen; R C Smith; K Watabe; Y Ichikawa; T Ichikawa; E M Davis; M M Le Beau; C W Rinker-Schaeffer
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

8.  Imaging findings of extrapulmonary metastases of osteosarcoma.

Authors:  Seung Ja Kim; Jung-Ah Choi; Sang Hyun Lee; Ja Young Choi; Sung Hwan Hong; Hye Won Chung; Heung Sik Kang
Journal:  Clin Imaging       Date:  2004 Jul-Aug       Impact factor: 1.605

Review 9.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

Review 10.  Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.

Authors:  Evan T Keller; Zheng Fu; Kam Yeung; Meghan Brennan
Journal:  Cancer Lett       Date:  2004-04-30       Impact factor: 8.679

View more
  91 in total

1.  Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Authors:  Yong Zhao; Mei-Juan Tu; Yi-Feng Yu; Wei-Peng Wang; Qiu-Xia Chen; Jing-Xin Qiu; Ai-Xi Yu; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2015-10-27       Impact factor: 5.858

2.  An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis.

Authors:  Seth D Goldstein; Masanori Hayashi; Catherine M Albert; Kyle W Jackson; David M Loeb
Journal:  Clin Exp Metastasis       Date:  2015-08-18       Impact factor: 5.150

3.  Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

Authors:  Jahnabi Roy; Payam Dibaeinia; Timothy M Fan; Saurabh Sinha; Aditi Das
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

4.  Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.

Authors:  Bai-Cheng He; Jian-Li Gao; Bing-Qiang Zhang; Qing Luo; Qiong Shi; Stephanie H Kim; Enyi Huang; Yanhong Gao; Ke Yang; Eric R Wagner; Linyuan Wang; Ni Tang; Jinyong Luo; Xing Liu; Mi Li; Yang Bi; Jikun Shen; Gaurav Luther; Ning Hu; Qixin Zhou; Hue H Luu; Rex C Haydon; Yingming Zhao; Tong-Chuan He
Journal:  Mol Pharmacol       Date:  2010-10-26       Impact factor: 4.436

5.  Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases.

Authors:  Jun Yuan; Christian Ossendorf; Jan P Szatkowski; James T Bronk; Avudaiappan Maran; Michael Yaszemski; Mark E Bolander; Gobinda Sarkar; Bruno Fuchs
Journal:  Cancer Invest       Date:  2009-05       Impact factor: 2.176

Review 6.  Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Robert E Brookover; Ryan M Garcia; Patrick J Getty; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

7.  Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.

Authors:  Jahnabi Roy; Josephine E Watson; In Sup Hong; Timothy M Fan; Aditi Das
Journal:  J Med Chem       Date:  2018-06-26       Impact factor: 7.446

8.  CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.

Authors:  Weike Si; Quan Kang; Hue H Luu; Jong Kyung Park; Qing Luo; Wen-Xin Song; Wei Jiang; Xiaoji Luo; Xinmin Li; Hong Yin; Anthony G Montag; Rex C Haydon; Tong-Chuan He
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials.

Authors:  Xiang Chen; Tong-Tao Yang; Wei Wang; Hong-Hui Sun; Bao-An Ma; Cun-Xiao Li; Qiong Ma; Zhe Yu; Qing-Yu Fan
Journal:  Cytotechnology       Date:  2009-11-29       Impact factor: 2.058

10.  Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.

Authors:  Yi Guo; Elyssa M Rubin; Jun Xie; Xiaolin Zi; Bang H Hoang
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.